Abstract
Until worldwide eradication of poliomyelitis is achieved, vaccination with poliovirus vaccines is the only means for providing population and individual immunity to polioviruses. The ACIP, AAP, and AAFP support the global poliomyelitis eradication initiative, and have recommended a transition policy that will increase use of IPV and decrease use of OPV during the next 3 to 5 years.